Loading clinical trials...
Loading clinical trials...
The objective of this trial is to determine the efficacy and safety of linaclotide administered to patients with chronic constipation (CC). The primary efficacy parameter is the percentage of patients...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Ironwood Pharmaceuticals, Inc.
Collaborators
NCT06847919 · Chronic Constipation
NCT03819062 · Chronic Constipation
NCT06354855 · Chronic Constipation
NCT06850415 · Slow Transit Constipation, Colonic Transit, and more
NCT04713085 · Chronic Constipation With Overflow, Encopresis With Constipation and Overflow Incontinence, and more
Ironwood Investigational Site
Birmingham, Alabama
Ironwood Investigational Site
Huntsville, Alabama
Ironwood Investigational Site
Chandler, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions